A Chinese investment group, Creat, has just bought the privatised NHS plasma supplier from Bain Capital – only three years after the American private equity firm bought the NHS’s Plasma Resources UK from the Department of Health in 2013.

This privatisation evaded Parliamentary scrutiny, as it was announced just as MPs were about to take six weeks holiday.It  involved the sale of 80% of Plasma Resources UK’s equity to the US private equity firm Bain Capital for £90m, plus a Bain Capital Investment of an extra £50m in the firm to create a “UK Life Sciences Champion.”